Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice; Public Hearing; Request for Comments

Document ID: FDA-2012-N-0170-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2012-05476
CFR Citation: 21 CFR Chapter I
View Document:  View as format pdf View as format html

Details Information

Abstract: Public Hearing on 4/23-24/2012 Registration due 4/2/2012 Comments due 5/31/2012
Document Subtype: Notice of Hearing
Received Date: March 06 2012, at 12:00 AM Eastern Standard Time
Start-End Page: 13513 - 13516
Page Count: 4
Comment Start Date: March 7 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: May 31 2012, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 30
PSPC Alliance - Comment
Posted: 04/16/2012     ID: FDA-2012-N-0170-0002

May 31,2012 11:59 PM ET
John Anthony Laczin - Comment
Posted: 04/16/2012     ID: FDA-2012-N-0170-0003

May 31,2012 11:59 PM ET
Association of Clinical Research Organizations (ACRO) - Comment
Posted: 04/16/2012     ID: FDA-2012-N-0170-0004

May 31,2012 11:59 PM ET
Regulatory Education and Action for Patients (REAP) - Comment
Posted: 04/16/2012     ID: FDA-2012-N-0170-0005

May 31,2012 11:59 PM ET
National Patient Advocate Foundation (NPAF) - Comment
Posted: 04/16/2012     ID: FDA-2012-N-0170-0006

May 31,2012 11:59 PM ET

Related Documents

    More
Total: 15
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Administrative Detention under the Food and Drug Administration Safety and Innovation Act
Tobacco Product Manufacturing Practice; Establishment of a Public Docket